Suppr超能文献

基于配体的μ-阿片受体构象空间研究。

Ligand based conformational space studies of the μ-opioid receptor.

机构信息

Universidade Regional do Cariri - URCA, Biological Chemistry Dept., Crato, CE 63105-000, Brazil.

Université Côte d'Azur, CNRS, Institut de Chimie de Nice UMR7272, Nice 06108, France.

出版信息

Biochim Biophys Acta Gen Subj. 2021 Mar;1865(3):129838. doi: 10.1016/j.bbagen.2020.129838. Epub 2020 Dec 26.

Abstract

BACKGROUND

G protein-coupled receptors (GPCRs) comprise a family of membrane proteins that can be activated by a variety of external factors. The μ-opioid receptor (MOR), a class A GPCR, is the main target of morphine. Recently, enhanced sampling molecular dynamics simulations of a constitutively active mutant of MOR in its apo form allowed us to capture the novel intermediate states of activation, as well as the active state. This prompted us to apply the same techniques to wild type MOR in complex with ligands, in order to explore their contributions to the receptor conformational changes in the activation process.

METHODS

MOR was modeled in complex with agonists (morphine, BU72), a partial agonist (naloxone benzoylhydrazone) and an antagonist (naloxone). Replica exchange with solute tempering (REST2) molecular dynamics simulations were carried out for all systems. Trajectory frames were clustered, and the activation state of each cluster was assessed by two different methods.

RESULTS

Cluster sizes and activation indices show that while agonists stabilized structures in a higher activation state, the antagonist behaved oppositely. Morphine tends to drive the receptor towards increasing R165-T279 distances, while naloxone tends to increase the NPxxYA motif conformational change.

CONCLUSIONS

Despite not observing a full transition between inactive and active states, an important conformational change of transmembrane helix 5 was observed and associated with a ligand-driven step of the process.

GENERAL SIGNIFICANCE

The activation process of GPCRs is widely studied but still not fully understood. Here we carried out a step forward in the direction of gaining more details of this process.

摘要

背景

G 蛋白偶联受体(GPCRs)是一类能够被多种外部因素激活的膜蛋白家族。μ-阿片受体(MOR)是 A 类 GPCR,是吗啡的主要靶点。最近,我们对 MOR 的apo 形式的组成型激活突变体进行了增强采样分子动力学模拟,从而捕获到了新的激活中间状态和活性状态。这促使我们将相同的技术应用于与配体结合的野生型 MOR,以探索它们在激活过程中对受体构象变化的贡献。

方法

我们将 MOR 与激动剂(吗啡、BU72)、部分激动剂(纳洛酮苯甲酰肼)和拮抗剂(纳洛酮)复合进行建模。我们对所有系统都进行了配体温度交换(REST2)分子动力学模拟。对轨迹帧进行聚类,并使用两种不同的方法评估每个簇的激活状态。

结果

簇大小和激活指数表明,激动剂稳定了处于更高激活状态的结构,而拮抗剂则表现相反。吗啡倾向于驱动受体增加 R165-T279 距离,而纳洛酮则倾向于增加 NPxxYA 基序的构象变化。

结论

尽管没有观察到从非活跃状态到活跃状态的完全转变,但观察到了跨膜螺旋 5 的重要构象变化,并与配体驱动的过程步骤相关。

一般意义

GPCR 的激活过程得到了广泛研究,但仍未完全理解。在这里,我们在获得该过程更多细节方面迈出了一步。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验